Diabetes 53:2143-2152, 2004
© 2004 by the American Diabetes Association, Inc.
Prospective Isolation of Multipotent Pancreatic Progenitors Using Flow-Cytometric Cell Sorting
Atsushi Suzuki1,2,
Hiromitsu Nakauchi3, and
Hideki Taniguchi2,4,5
1 Gene Expression Laboratories, The Salk Institute for Biological Studies, La Jolla, California
2 Department of Surgery, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan
3 Laboratory of Stem Cell Therapy, Center for Experimental Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan
4 Department of Regenerative Medicine, Faculty of Medicine, Yokohama City University, Yokohama, Kanagawa, Japan
5 Research Unit for Organ Regeneration, Center for Developmental Biology, The Institute of Physical and Chemical Research (RIKEN), Kobe, Hyogo, Japan
During pancreatic development, neogenesis, and regeneration, stem cells might act as a central player to generate endocrine, acinar, and duct cells. Although these cells are well known as pancreatic stem cells (PSCs), indisputable proof of their existence has not been reported. Identification of phenotypic markers for PSCs leads to their prospective isolation and precise characterization to clear whether stem cells exist in the pancreas. By combining flow cytometry and clonal analysis, we show here that a possible pancreatic stem or progenitor cell candidate that resides in the developing and adult mouse pancreas expresses the receptor for the hepatocyte growth factor (HGF) c-Met, but does not express hematopoietic and vascular endothelial antigens such as CD45, TER119, c-Kit, and Flk-1. These cells formed clonal colonies in vitro and differentiated into multiple pancreatic lineage cells from single cells. Some of them could largely expand with self-renewing cell divisions in culture, and, following cell transplantation, they differentiated into pancreatic endocrine and acinar cells in vivo. Furthermore, they produced cells expressing multiple markers of nonpancreatic organs including liver, stomach, and intestine in vitro. Our data strongly suggest that c-Met/HGF signaling plays an important role in stem/progenitor cell function in both developing and adult pancreas. By using this antigen, PSCs could be isolated prospectively, enabling a detailed investigation of stem cell markers and application toward regenerative therapies for diabetes.
Address correspondence and reprint requests to Hideki Taniguchi, MD, PhD, Department of Regenerative Medicine, Faculty of Medicine, Yokohama City University, 3-9 Fuku-ura, Kanazawa-ku, Yokohama, Kanagawa 236-0004, Japan. E-mail: rtanigu{at}med.yokohama-cu.ac.jp

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Okuno, K. Minami, A. Okumachi, K. Miyawaki, N. Yokoi, S. Toyokuni, and S. Seino
Generation of insulin-secreting cells from pancreatic acinar cells of animal models of type 1 diabetes
Am J Physiol Endocrinol Metab,
January 1, 2007;
292(1):
E158 - E165.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Yin, J. Tao, D. D. Lee, J. Shen, M. Hara, J. Lopez, A. Kuznetsov, L. H. Philipson, and A. S. Chong
Recovery of Islet {beta}-Cell Function in Streptozotocin- Induced Diabetic Mice: An Indirect Role for the Spleen
Diabetes,
December 1, 2006;
55(12):
3256 - 3263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. P. Fadini and A. Avogaro
Autologous transplantation of granulocyte colony-stimulating factor- mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes.
Diabetes Care,
February 1, 2006;
29(2):
478 - 479.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Means, I. M. Meszoely, K. Suzuki, Y. Miyamoto, A. K. Rustgi, R. J. Coffey Jr, C. V. E. Wright, D. A. Stoffers, and S. D. Leach
Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates
Development,
August 15, 2005;
132(16):
3767 - 3776.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Roccisana, V. Reddy, R. C. Vasavada, J. A. Gonzalez-Pertusa, M. A. Magnuson, and A. Garcia-Ocana
Targeted Inactivation of Hepatocyte Growth Factor Receptor c-met in {beta}-Cells Leads to Defective Insulin Secretion and GLUT-2 Downregulation Without Alteration of {beta}-Cell Mass
Diabetes,
July 1, 2005;
54(7):
2090 - 2102.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Fujikawa, S.-H. Oh, L. Pi, H. M. Hatch, T. Shupe, and B. E. Petersen
Teratoma Formation Leads to Failure of Treatment for Type I Diabetes Using Embryonic Stem Cell-Derived Insulin-Producing Cells
Am. J. Pathol.,
June 1, 2005;
166(6):
1781 - 1791.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Gershengorn, A. A. Hardikar, C. Wei, E. Geras-Raaka, B. Marcus-Samuels, and B. M. Raaka
Epithelial-to-Mesenchymal Transition Generates Proliferative Human Islet Precursor Cells
Science,
December 24, 2004;
306(5705):
2261 - 2264.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Diabetes Association.
|
|
| |
|